%0 Journal Article
%B European Psychiatry
%D 2013
%G Eng
%M 21964484
%P 49-52
%T Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial
%V 28
%2 PMID 21964484 [Impact Factor 2.7]
%7 2011/10/04
%@ 1778-3585 (Electronic)0924-9338 (Linking)